Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Down on Analyst Downgrade

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price gapped down before the market opened on Friday after Truist Financial lowered their price target on the stock from $10.00 to $9.00. The stock had previously closed at $6.34, but opened at $6.03. Truist Financial currently has a hold rating on the stock. Aveanna Healthcare shares last traded at $6.44, with a volume of 496,743 shares changing hands.

A number of other equities research analysts have also weighed in on the stock. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective for the company in a report on Friday. Royal Bank Of Canada boosted their target price on Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a research note on Thursday, January 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Finally, UBS Group boosted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, January 15th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $10.94.

Insider Activity at Aveanna Healthcare

In related news, CEO Jeff Shaner sold 173,225 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $1,248,952.25. Following the completion of the sale, the chief executive officer owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. This represents a 6.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $132,923.56. Following the completion of the sale, the insider directly owned 337,755 shares in the company, valued at $2,435,213.55. This represents a 5.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 998,595 shares of company stock worth $7,567,770 in the last three months. Insiders own 7.80% of the company’s stock.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results materially beat estimates — Aveanna reported revenue of $662.5M (up ~27% YoY) and an EPS beat (reported $0.83 vs. consensus near $0.13). The strong top‑line growth and big EPS beat are the main bullish catalysts. GlobeNewswire Q4 Results
• Positive Sentiment: Raymond James upgraded AVAH from Outperform to Strong‑Buy and set a $13 price target (~~97% above the recent price), which likely boosted investor demand and sentiment. Finviz (Raymond James Upgrade)
• Neutral Sentiment: Earnings call / transcripts available for detail — Investors can review management’s commentary on margins, organic growth and reimbursement trends in the Q4 call transcript to assess sustainability of recent results. Earnings Call Transcript
• Neutral Sentiment: Short‑interest data in recent reports appears unreliable/zeroed out (reported as 0 shares), so it doesn’t provide a clear signal on positioning or potential squeezes at the moment.
• Negative Sentiment: Fiscal‑2026 revenue/growth outlook disappointed some analysts and investors — coverage noted that the company’s revenue outlook trailed consensus, which pressured the stock despite the Q4 beat. That guidance miss is the main bearish offset to today’s gains. MSN (Guidance Miss)
• Negative Sentiment: Some outlets flagged the fiscal‑2026 guidance update as a reason for intracday weakness after the initial pop, highlighting that near‑term growth assumptions and reimbursement dynamics will be key watchpoints for investors. TipRanks (Guidance & Outlook)

Institutional Investors Weigh In On Aveanna Healthcare

Several large investors have recently modified their holdings of the stock. Teacher Retirement System of Texas increased its stake in Aveanna Healthcare by 232.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 224,375 shares of the company’s stock worth $1,990,000 after purchasing an additional 156,947 shares in the last quarter. AustralianSuper Pty Ltd acquired a new position in shares of Aveanna Healthcare in the third quarter worth about $15,743,000. Assenagon Asset Management S.A. acquired a new stake in shares of Aveanna Healthcare during the third quarter valued at approximately $7,356,000. Squarepoint Ops LLC boosted its stake in Aveanna Healthcare by 207.0% in the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after purchasing an additional 323,656 shares during the period. Finally, Algert Global LLC grew its position in Aveanna Healthcare by 120.1% during the 3rd quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after purchasing an additional 557,898 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Price Performance

The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23. The company has a market cap of $1.37 billion, a PE ratio of 18.16 and a beta of 2.07. The stock has a fifty day moving average price of $7.88 and a 200-day moving average price of $8.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.